Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Neuropathology and Applied Neurobiology|June 12, 2024
Amino-terminally elongated Aβ peptides are generated by the secreted metalloprotease ADAMTS4 and deposit in a subset of Alzheimer's disease brainsOliver Wirths, Christina Lehnen, Merle Fricke, et al.
The American Journal of Pathology|March 25, 2004
Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's diseaseChristoph Schmitz, Bart P F Rutten, Andrea Pielen, et al.
Elife|February 9, 2026
Aggregation-dependent epitope sequence and modification fingerprints of anti-Aβ antibodiesIvan Talucci, Timon Leske, Hans-Wolfgang Klafki, et al.
Journal of Neuropathology and Experimental Neurology|February 8, 2006
OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomasTalitha de Haas, Esmeralda Oussoren, Wieslawa Grajkowska, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 21, 2026
Evaluation of fully automated ApoE4 proteotyping for <i>APOE</i> ε4 genotype estimation in the FINDERI cohortHans-Wolfgang Klafki, Carlotta Derad, Maike Hoberg, et al.
Acta Neuropathologica Communications|November 21, 2013
The Arctic AβPP mutation leads to Alzheimer's disease pathology with highly variable topographic deposition of differentially truncated AβHannu Kalimo, Maciej Lalowski, Nenad Bogdanovic, et al.
Acta Neuropathologica|December 3, 2024
Identification of isoAsp7-Aβ as a major Aβ variant in Alzheimer's disease, dementia with Lewy bodies and vascular dementiaSarah Schrempel, Anna Katharina Kottwitz, Anke Piechotta, et al.
Acta Neuropathologica|November 15, 2018
The metalloprotease ADAMTS4 generates N-truncated Aβ4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's diseaseSusanne Walter, Thorsten Jumpertz, Melanie Hüttenrauch, et al.
The American Journal of Pathology|October 7, 2004
Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic modelCaty Casas, Nicolas Sergeant, Jean-Michel Itier, et al.
Pageof 12